Related Experiment Video
Updated: Jan 21, 2026

In Vivo Evaluation of the Mechanical and Viscoelastic Properties of the Rat Tongue
Published on: July 6, 2017
Allocryptopine: A Review of Its Properties and Mechanism of Antiarrhythmic Effect
Jie Li1, Bin Li2, Hailiang Huang1
1Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
Abstract:
Abstract:Throughout the last decade, extensive efforts have been devoted to developing a percutaneous catheter ablation and implantable cardioverter-defibrillator technique for patients suffering from ventricular arrhythmia. Antiarrhythmic drug efficacy for preventing arrhythmias remains disappointing because of adverse cardiovascular effects. Allocryptopine is an isoquinoline alkaloid widely present in medicinal herbs. Studies have indicated that allocryptopine exhibits potential anti-arrhythmic actions in various animal models. The potential therapeutic benefit of allocryptopine in arrhythmia diseases is addressed in this study, focusing on multiple ion channel targets and reduced repolarization dispersion. The limitations of allocryptopine research are clear given a lack of parameters regarding toxicology and pharmacokinetics and clinical efficacy in patients with ventricular arrhythmias. Much remains to be revealed about the properties of allocryptopine.
More Related Videos
11:19Characterizing Multiscale Mechanical Properties of Brain Tissue Using Atomic Force Microscopy, Impact Indentation, and Rheometry
Published on: September 6, 2016
10:24Quantifying the Mechanical Properties of the Endothelial Glycocalyx with Atomic Force Microscopy
Published on: February 21, 2013
Related Concept Videos
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Physical and Chemical Properties of Matter
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers